Cargando…
IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
BACKGROUND: Due to the low survival rate of cell transplantation, stem cell has not been widely used in clinical treatment of acute myocardial infarction (AMI). In this study, we immobilized the C domain peptide of insulin-like growth factor-1 on chitosan (CS-IGF-1C) to obtain bioactive hydrogel. Th...
Autores principales: | Yao, Yong, Yang, Liang, Feng, Li-feng, Yue, Zhi-wei, Zhao, Nian-huan, Li, Zongjin, He, Zuo-xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098145/ https://www.ncbi.nlm.nih.gov/pubmed/32216819 http://dx.doi.org/10.1186/s13287-020-01637-3 |
Ejemplares similares
-
Correction to: IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
por: Yao, Yong, et al.
Publicado: (2020) -
IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia
por: Zhao, Nianhuan, et al.
Publicado: (2019) -
Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy
por: Wang, Hongfeng, et al.
Publicado: (2020) -
Are AMI Patients with Comorbid Mental Illness More Likely to be Admitted to Hospitals with Lower Quality of AMI Care?
por: Cai, Xueya, et al.
Publicado: (2013) -
Two-step generation of mesenchymal stem/stromal cells from human pluripotent stem cells with reinforced efficacy upon osteoarthritis rabbits by HA hydrogel
por: Zhang, Leisheng, et al.
Publicado: (2021)